OrthoPediatrics’ (KIDS) “Hold” Rating Reaffirmed at Truist Financial

Truist Financial reiterated their hold rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research note released on Thursday, Benzinga reports. Truist Financial currently has a $30.00 target price on the stock, down from their prior target price of $35.00.

A number of other brokerages also recently weighed in on KIDS. Needham & Company LLC boosted their target price on shares of OrthoPediatrics from $37.00 to $42.00 and gave the stock a buy rating in a research note on Tuesday, May 7th. JMP Securities reaffirmed a market outperform rating and issued a $50.00 target price on shares of OrthoPediatrics in a research note on Tuesday, May 7th.

OrthoPediatrics Price Performance

KIDS stock traded down $1.37 during trading on Thursday, hitting $26.91. 123,016 shares of the stock traded hands, compared to its average volume of 170,048. OrthoPediatrics has a one year low of $23.10 and a one year high of $40.22. The stock has a market cap of $641.24 million, a price-to-earnings ratio of -28.03 and a beta of 1.19. The company has a current ratio of 4.45, a quick ratio of 1.99 and a debt-to-equity ratio of 0.03. The company has a 50 day simple moving average of $30.73 and a 200 day simple moving average of $29.74.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Monday, May 6th. The company reported ($0.30) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.42) by $0.12. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. The company had revenue of $44.69 million during the quarter, compared to the consensus estimate of $41.63 million. Equities analysts expect that OrthoPediatrics will post -1.2 EPS for the current fiscal year.

Institutional Investors Weigh In On OrthoPediatrics

Several institutional investors have recently modified their holdings of KIDS. Wellington Management Group LLP acquired a new stake in shares of OrthoPediatrics during the 4th quarter worth approximately $10,214,000. Granahan Investment Management LLC grew its position in shares of OrthoPediatrics by 30.0% during the 4th quarter. Granahan Investment Management LLC now owns 769,245 shares of the company’s stock worth $25,008,000 after buying an additional 177,640 shares during the period. Kennedy Capital Management LLC acquired a new position in OrthoPediatrics during the first quarter valued at approximately $2,894,000. Wasatch Advisors LP grew its holdings in OrthoPediatrics by 21.2% during the first quarter. Wasatch Advisors LP now owns 501,310 shares of the company’s stock valued at $14,618,000 after purchasing an additional 87,657 shares during the period. Finally, AWM Investment Company Inc. grew its holdings in OrthoPediatrics by 14.6% during the first quarter. AWM Investment Company Inc. now owns 487,619 shares of the company’s stock valued at $14,219,000 after purchasing an additional 62,000 shares during the period. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.